Our Technology Platform
How Our Platform Works
Auravita’s technology integrates three core innovations:
1.Lipid-Raft Targeting
A proprietary delivery approach that conjugates therapeutic antibodies to lipid-raft-modulating payloads, enabling targeted and reversible modulation of cell signaling, clonal expansion, and cellular function.
3. Platform Modularity
The chemistry is payload-agnostic and disease-agnostic, enabling rapid adaptation for:
Autoimmune & Inflammatory Disorders
Immune-metabolic diseases
Oncology-adjacent inflammation
Neuroinflammatory & proteinopathy-related signaling dysfunction
Other conditions driven by lipid-raft dysregulation
2. Controlled Modulation of Immune Signaling
By influencing lipid-raft coalescence, our therapeutics can adjust receptor clustering and downstream signaling strength, reducing excessive inflammatory activation while preserving normal immune function.